Difference between revisions of "3M Pharmaceuticals"
(reinstating affiliations) |
m |
||
Line 1: | Line 1: | ||
− | In the latter part of 2006, [[Meda]] announced completion its acquisition of the pharmaceutical division of 3M in Europe. <ref> Zenopa [http://www.zenopa.com/news_story.php?id=18021894 Meda completes 3M Pharmaceuticals acquisition in Europe] | + | ==Background== |
+ | In the latter part of 2006, [[Meda]] announced completion its acquisition of the pharmaceutical division of 3M in Europe. <ref> Zenopa [http://www.zenopa.com/news_story.php?id=18021894 Meda completes 3M Pharmaceuticals acquisition in Europe] Accessed 15th December 2007</ref> | ||
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to [[Graceway Pharmaceuticals Inc.]] at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to [[Ironbridge Capital]] and [[Archer Capital]]. <ref> 3M [http://solutions.3m.com/wps/portal/3M/en_GB/EU-HealthCare/Home/NewsEvents/News/?PC_7_RJH9U5230GE3E02LECIE20S5D5_assetId=1170423557934 3M Reaches Agreements to Sell its Pharmaceuticals Business] Accessed 15th December 2007</ref> | At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to [[Graceway Pharmaceuticals Inc.]] at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to [[Ironbridge Capital]] and [[Archer Capital]]. <ref> 3M [http://solutions.3m.com/wps/portal/3M/en_GB/EU-HealthCare/Home/NewsEvents/News/?PC_7_RJH9U5230GE3E02LECIE20S5D5_assetId=1170423557934 3M Reaches Agreements to Sell its Pharmaceuticals Business] Accessed 15th December 2007</ref> |
Revision as of 11:39, 16 December 2007
Background
In the latter part of 2006, Meda announced completion its acquisition of the pharmaceutical division of 3M in Europe. [1]
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to Graceway Pharmaceuticals Inc. at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to Ironbridge Capital and Archer Capital. [2]
Affiliations
3M Pharmaceuticals is listed as a member of the Pharmaceutical Research and Manufacturers of America (PHRMA) in 2005[3] and 2006 [4].
References
- ↑ Zenopa Meda completes 3M Pharmaceuticals acquisition in Europe Accessed 15th December 2007
- ↑ 3M 3M Reaches Agreements to Sell its Pharmaceuticals Business Accessed 15th December 2007
- ↑ PHRMA 2005 Industry Profile Accessed 16th December 2007
- ↑ PHRMA 2006 Member Company List Accessed 16th December 2007